Are Biotech Investors Still Being Led By Science Fundamentals?

Interview With Rising Leader John Cassidy

06 Jul 2021

• By William Masters

From the Aduhelm approval to exuberant stock markets, life sciences investor and In Vivo Rising Leader John Cassidy shares insights into industry trends, highlighting areas where decisions may have moved away from scientific fundamentals.

Is The Industry Still Following The Science? • Source: Alamy

Back To Rising Leaders Gallery

Being ‘led by the science’ is a principle that everyone in the industry, from investors to R&D teams, seems agrees on – at least in theory. In practice there are...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Rising Leaders 2025: Pedro Valencia’s ADC Vision At AbbVie

26 May 2025

• By Jo Shorthouse

From chemical engineering to cancer innovation, AbbVie's rising oncology leader is advancing next-generation ADCs to tackle difficult-to-treat tumors with a patient-centered approach.

Rising Leaders 2025: Rob Barrow On Leading MindMed’s Psychedelic Renaissance

09 May 2025

• By Jo Shorthouse

Rob Barrow's unconventional journey from finance to leading MindMed highlights his innovative approach to psychedelic medicine, aiming to transform mental health treatment with groundbreaking therapies.

Rising Leaders 2025: Stefan König On The Joy Of Watching Talent Grow

07 May 2025

• By Urtė Fultinavičiūtė

While there might be different recipes for success in leadership, continuous learning and wide-ranging experiences have made Stefan König ready to lead Merz Therapeutics as CEO.

Rising Leaders 2025: Flagship’s Jacob Rubens On Building The Next Generation Of Biotech

05 May 2025

• By David Wild

Rising Leader Jacob Rubens, who has co-founded and led several Flagship companies and is now origination partner, believes aspiring leaders should follow their bliss.

How Vir Bio CEO Marianne De Backer Is Rebuilding Commercial Momentum

20 May 2025

• By David Wild

From billion-dollar COVID antibody to a strategic reset, Marianne De Backer is navigating Vir's comeback through pipeline focus and disciplined leadership.